MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
The journal of pharmacology and experimental therapeutics/The Journal of pharmacology and experimental therapeutics